Amisulprida (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Amisulprida" in Spanish language version.

refsWebsite

Global rank Spanish rank

low place

low place

2^nd place

2^nd place

4^th place

4^th place

447^th place

668^th place

1medicinescomplete.com

low place

low place

1web.archive.org

1^st place

1^st place

57^th place

3^rd place

doi.org

dx.doi.org

Pani L, Gessa GL (2002). «The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia». Molecular Psychiatry 7 (3): 247-53. PMID 11920152. doi:10.1038/sj.mp.4001040.
De Silva, V; Hanwella, R (April 2008). «Pharmaceutical patents and the quality of mental healthcare in low- and middle-income countries». The Psychiatrist 32 (4): 121-23. doi:10.1192/pb.bp.107.015651.
Grattan V, Vaino AR, Prensky Z, Hixon MS (August 2019). «Antipsychotic Benzamides Amisulpride and LB-102 Display Polypharmacy as Racemates, S Enantiomers Engage Receptors D2 and D3, while R Enantiomers Engage 5-HT7». ACS Omega 4 (9): 14151-4. ISSN 2470-1343. PMC 6714530. PMID 31497735. doi:10.1021/acsomega.9b02144.

fda.gov

accessdata.fda.gov

«Barhemsys (amisulpride) injection, for intravenous use». U.S. Food and Drug Administration (FDA). February 2020. Consultado el 26 de febrero de 2020.

issn.org

portal.issn.org

Grattan V, Vaino AR, Prensky Z, Hixon MS (August 2019). «Antipsychotic Benzamides Amisulpride and LB-102 Display Polypharmacy as Racemates, S Enantiomers Engage Receptors D2 and D3, while R Enantiomers Engage 5-HT7». ACS Omega 4 (9): 14151-4. ISSN 2470-1343. PMC 6714530. PMID 31497735. doi:10.1021/acsomega.9b02144.

lbpharma.us

«Pipeline». LB Pharmaceuticals. Archivado desde el original el 10 de julio de 2019. Consultado el 29 de agosto de 2019.
«About Us». LB Pharmaceuticals. Consultado el 26 de febrero de 2020.
«Data presented at 2017 ECNP meeting (European Neuropsychopharmacology, 2017, 27 (S4), S922-S923)». LB Pharmaceuticals. Consultado el 26 de febrero de 2020.
«Building a translational bridge from animals to man for clinical candidate LB-102, a next-generation benzamide antipsychotic (P.101)». LB Pharmaceuticals. Consultado el 29 de agosto de 2019.

medicinescomplete.com

Brayfield, A, ed. (June 2017). «Amisulpride: Martindale: The Complete Drug Reference». MedicineComplete. Pharmaceutical Press. Consultado el 5 de agosto de 2017.

nih.gov

ncbi.nlm.nih.gov

Pani L, Gessa GL (2002). «The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia». Molecular Psychiatry 7 (3): 247-53. PMID 11920152. doi:10.1038/sj.mp.4001040.
Grattan V, Vaino AR, Prensky Z, Hixon MS (August 2019). «Antipsychotic Benzamides Amisulpride and LB-102 Display Polypharmacy as Racemates, S Enantiomers Engage Receptors D2 and D3, while R Enantiomers Engage 5-HT7». ACS Omega 4 (9): 14151-4. ISSN 2470-1343. PMC 6714530. PMID 31497735. doi:10.1021/acsomega.9b02144.

web.archive.org

«Pipeline». LB Pharmaceuticals. Archivado desde el original el 10 de julio de 2019. Consultado el 29 de agosto de 2019.